We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Study of Rocuronium-Sugammadex as an Alternative to Succinylcholine-Cisatracurium in Microlaryngeal Surgery.
- Authors
Aragón‐Benedí, Cristian; Visiedo‐Sánchez, Sara; Pascual‐Bellosta, Ana; Ortega‐Lucea, Sonia; Fernández‐Liesa, Rafael; Martínez‐Ubieto, Javier; Aragón-Benedí, Cristian; Visiedo-Sánchez, Sara; Pascual-Bellosta, Ana; Ortega-Lucea, Sonia; Fernández-Liesa, Rafael; Martínez-Ubieto, Javier; Research Group in Anesthesia, Resuscitation AND Perioperative Medicine of Aragón Health Research Institute (IIS Aragón)
- Abstract
Microlaryngeal surgery (ML) is a short procedure that requires a deep neuromuscular blockade to provide optimum surgical conditions. Succinylcholine is a relaxant widely used but involves numerous complications. One valid alternative is rocuronium, with a specific antagonist, sugammadex. The primary objective was to assess the surgical conditions in ML according to the relaxant. The secondary objectives were to assess intubation conditions and intraoperative and immediate postoperative adverse events.Study Design: Prospective randomized study.Methods: This was a prospective study of patients scheduled for ML randomized into two groups according to relaxant. Neuromuscular blockade was recorded after administration and during ML surgery. Surgical conditions were assessed using the ML Rating Scale, intubation conditions, remifentanil doses, intraoperative complications, surgery time, emergence time, and complications in the postanesthesia care unit.Results: Two hundred five patients were included (rocuronium = 103, succinylcholine = 102). Train-of-four values were higher for rocuronium, though the otorhinolaryngology surgical conditions were significantly better in that group (rocuronium = 5.54 ± 1.39 points; succinylcholine = 9.13 ± 1.99 points). Intubation conditions were similar in both groups. Remifentanil doses were higher for succinylcholine (P Conclusions: Rocuronium provides better surgical conditions and allows for the use of lower doses of remifentanil as compared to succinylcholine and cisatracurium in ML. This makes it possible to decrease the time to awakening and the complications associated with high doses of remifentanil.Level Of Evidence: 1b Laryngoscope, 131:E212-E218, 2021.
- Subjects
NEUROMUSCULAR blockade; SUGAMMADEX; ROCURONIUM bromide; EXPERIMENTAL design; SURGICAL complications; LARYNGEAL surgery; SUCCINYLCHOLINE; RESEARCH; NEUROMUSCULAR depolarizing agents; COMBINATION drug therapy; OPERATIVE surgery; RESEARCH methodology; EVALUATION research; MEDICAL cooperation; COMPARATIVE studies; RANDOMIZED controlled trials; CURARE-like agents; LARYNGEAL diseases; BLIND experiment; RESEARCH funding; ATRACURIUM; LONGITUDINAL method
- Publication
Laryngoscope, 2021, Vol 131, Issue 1, pE212
- ISSN
0023-852X
- Publication type
Academic Journal
- DOI
10.1002/lary.28649